Neuro Emergencies, Neurodegeneration, an...

Neuro Emergencies, Neurodegeneration, an...

Audio by Paper2Audio

Neuro Emergencies, Neurodegeneration, and Wound Care: The Complete N.P Exam Lecture

Introduction

Hey there, and welcome to this review session. Grab your coffee, settle into your commute, or lace up for a walk, because over the next while we're going to work through everything you need to know for your Neuro and Wound exam — and honestly, everything you need to know to not miss something dangerous in clinical practice.

Here's what we're covering today: stroke and T.I.A, seizures and epilepsy, headache and concussion, the neurodegenerative disorders — that's Alzheimer's, Parkinson's, A.L.S, frontotemporal dementia, and Lewy body dementia — then we move into neuroimmunology and peripheral nerve disorders, and we'll finish with wound care: diabetic, venous, arterial, and pressure wounds.

Now, why does this matter clinically, beyond just passing the test? Because this content cluster is where nurse practitioners make life-or-death triage decisions. Someone walks into your clinic with new dizziness, or a headache, or a droopy face, or a wound that "just won't heal" — and your very first job, before you diagnose anything, is to answer one question: is this safe to manage here, right now, in this setting, or does this patient need to go to the emergency department immediately?

That's really the deep structure underneath almost every exam question in this unit. The test isn't really asking "do you know the name of the disease." It's asking "do you know which finding means stop everything and act."

So as we go through each topic, I want you to keep a running mental list of the red flags — the findings that flip a case from "routine outpatient" to "this needs emergency-level urgency right now." I'll call these out explicitly as we go, and we'll do a full red-flag roundup near the end. Let's get into it.

Chapter One: Stroke and T.I.A

Let's start with stroke, because it's probably the single highest-yield topic in this whole unit, and it's the one where speed of thinking really matters.

The first and most important question

When a patient presents with sudden neurologic symptoms — say, facial droop, arm weakness, or trouble speaking — the very first historical question you need to ask is: "When was the patient last known well?" Not "when did symptoms start," because sometimes patients wake up with symptoms and you don't actually know when they began. "Last known well" means the last time someone can confirm the patient was neurologically normal.

This single data point determines whether the patient is even eligible for time-sensitive treatments like thrombolysis — that's clot-busting medication — or mechanical thrombectomy, which is a procedure to physically remove a clot from a blood vessel in the brain. The key point to remember is: time is brain. Every minute that a stroke goes untreated, more brain tissue dies. So this question comes before your neuro exam, before your imaging orders — it comes first, always.

Don't forget the stroke mimic

Right alongside last known well, you need a point-of-care glucose check, and I mean early — like, as part of your very first assessment. Why? Because hypoglycemia, low blood sugar, can produce a clinical picture that looks exactly like a stroke: confusion, weakness, even focal deficits. And here's the beautiful thing — it's rapidly reversible.

If you give glucose and the "stroke" resolves in minutes, you've just saved that patient an unnecessary thrombolytic infusion and probably a hospital admission. So: glucose check, every single time, right at the start.

Posterior circulation stroke — the "Deadly D's"

Now here's a spot where students get tripped up. When we think "stroke," we tend to picture the classic anterior circulation picture — facial droop, arm weakness, slurred speech. But strokes affecting the posterior circulation — that's the vertebrobasilar system, supplying the brainstem and cerebellum — can look completely different. They can look like plain old vertigo. And that's dangerous, because vertigo gets brushed off as "probably just inner ear" all the time.

So how do you catch a posterior circulation stroke? Memorize the "Deadly D's": Dizziness or vertigo, Diplopia — that's double vision, Dysarthria — slurred speech, Dysphagia — difficulty swallowing, and Dystaxia or ataxia — that's incoordination, an unsteady gait. A common exam question focuses on exactly this: a patient with "just vertigo" who also has one or two of these other D's. That combination should make you think brainstem, not inner ear, and it should escalate your workup.

Imaging and the acute pathway

Once you suspect an acute stroke, the first imaging test is a non-contrast C.T scan of the head. Now, here's a subtlety that trips people up: this C.T is not being done to prove there's an ischemic stroke. Early ischemic strokes often look completely normal on non-contrast C.T in the first several hours. The C.T's job at this stage is to rule out hemorrhage — because if there's bleeding in the brain, you absolutely cannot give clot-busting medication, that would be catastrophic. So: C.T first, to rule out hemorrhage, not to rule in ischemia.

If the C.T is clean and the patient has a disabling stroke within the treatment time window, and there's evidence on C.T.A — that's C.T angiography, which images the blood vessels — of a large vessel occlusion, or L.V.O, then you're moving toward two things simultaneously: evaluation for I.V thrombolysis, and activation of the pathway for mechanical thrombectomy, where an interventional team physically retrieves the clot. Clinically, this matters because these patients often need transfer to a comprehensive stroke center capable of thrombectomy, and that transfer decision needs to happen fast.

Reversing anticoagulation in hemorrhage

Here's a very testable fact: if a patient on warfarin develops an intracerebral hemorrhage, how do you reverse that anticoagulation? The answer is four-factor prothrombic complex concentrate — we call it 4-factor P.C.C — plus I.V vitamin K. The P.C.C works fast to replace the clotting factors that warfarin has been suppressing, and the vitamin K sustains that reversal over a longer period, because P.C.C's effect is temporary. This is a classic paired-answer question on exams: P.C.C alone isn't enough, vitamin K alone is too slow — you need both together.

Stroke subtypes — knowing your patterns

Let's talk about the different flavors of ischemic stroke, because the exam loves to test pattern recognition here.

Lacunar stroke comes from small vessel disease — tiny, deep infarcts, usually in areas like the basal ganglia or internal capsule. The classic teaching point is that lacunar strokes tend to cause pure motor or pure sensory deficits — meaning weakness only, or numbness only — without what we call "cortical signs." Cortical signs would be things like aphasia, which is language impairment, neglect, which is inattention to one side of the body or space, or visual field loss. So if you see a pure motor stroke with no language problem, no neglect, no visual field cut — think lacunar, think small vessel disease.

Now, cardioembolic stroke — this is the one associated with atrial fibrillation. In A.Fib, blood pools in a poorly contracting atrium, clots form, and those clots can travel to the brain. The key management point: these patients generally need long-term oral anticoagulation, and for most patients with non-valvular A.Fib who don't have a contraindication, a doak — a direct oral anticoagulant, like apixaban or rivaroxaban — is preferred over warfarin. Clinically, this matters because doak's have more predictable dosing and don't require the frequent monitoring that warfarin does.

Then there's the category of minor non-cardioembolic stroke or high-risk T.I.A — tran-zee-unt ischemic attack, meaning symptoms that resolved. For these patients, the evidence supports short-term dual antiplatelet therapy — that's typically aspirin plus clopidogrel — for a limited window, followed by a transition to single-agent therapy. The key point to remember is that long-term dual antiplatelet therapy is generally avoided, because the bleeding risk climbs the longer you stay on two antiplatelets, and that risk eventually outweighs the stroke-prevention benefit. This is a common exam trap — students want to keep patients on dapt indefinitely because "more antiplatelet coverage sounds safer," but the correct answer is usually a defined short course, then de-escalate.

After the acute event — secondary prevention and follow-up

Stroke care doesn't end at discharge. Post-stroke follow-up should be a recurring, structured screen for depression, cognitive changes, swallowing problems — because dysphagia raises aspiration risk — falls, medication adherence, safety at home, and overall quality of life. This is the N.P's bread and butter: the acute event gets you into the system, but chronic, longitudinal management is where you'll spend most of your time with these patients.

Let's pause and consolidate stroke before we move on. The pattern to remember: last known well, glucose check, non-contrast C.T to rule out hemorrhage, C.T.A if you suspect a large vessel occlusion, and know your reversal agents and your antithrombotic strategies by stroke subtype. Got it? Good — let's move to seizures.

Chapter Two: Seizures and Epilepsy

Classifying seizures and telling them apart from mimics

A focal aware seizure is one where awareness is fully preserved — the patient knows what's happening to them the whole time. Symptoms can be surprisingly subtle and internal: déjà vu, an epigastric rising sensation — that's a strange feeling starting in the stomach and rising upward, unusual smells, visual disturbances, or one-sided sensory symptoms like tingling. These can be easy to miss or misattribute if you're not thinking "could this be a seizure."

Now, one of the classic differentiation challenges on exams is syncope versus seizure. They can look similar to a bystander — someone loses consciousness and falls — but the details differentiate them. Syncope tends to be brief, often less than 30 seconds, with rapid recovery — the patient is basically back to normal almost immediately.

Epileptic seizures, on the other hand, often involve lateral tongue biting — biting the side of the tongue, not the tip, prolonged postictal confusion — meaning after the seizure, the patient stays confused or groggy for a while, and stereotyped motor activity — repetitive, patterned movements. A common exam question focuses on exactly that recovery time: rapid return to baseline points you toward syncope; a foggy, confused patient for twenty minutes afterward points you toward seizure.

Here's a testable pearl connecting the two: because cardiac arrhythmias can also cause sudden loss of consciousness and can masquerade as a "seizure," any first episode of unexplained loss of consciousness should include a 12-lead E.C.G. You're screening for dangerous rhythm problems that could otherwise go undiagnosed and potentially be fatal.

When can you call it epilepsy?

This is a definitional question that shows up constantly: epilepsy is diagnosed after two unprovoked seizures occurring more than 24 hours apart. That's the key phrase — unprovoked. If a patient has a seizure because their blood sugar crashed to a dangerously low level, that's a provoked seizure, and a single provoked seizure does not establish a diagnosis of epilepsy. Fix the underlying trigger, and you may never see another seizure from that patient. This distinction matters enormously for how you counsel patients and whether you start long-term antiseizure medication.

Choosing medications — and a key pregnancy consideration

Let's talk drug selection, because this is one of the more nuanced, practice-relevant pieces of this unit. For focal-onset seizures in a woman who may become pregnant, levetiracetam is generally preferred over valproate. Why? Because valproate carries major teratogenic risk — meaning it can cause birth defects — and it's also linked to neurodevelopmental problems in children exposed in yoo-tuh-roh. This is a huge patient-safety issue, and it's exactly the kind of clinical-reasoning question you'll see on boards: "which medication would you avoid in a patient of reproductive age?" The answer is valproate, when a reasonable alternative exists.

Now, levetiracetam isn't without its own issues — you need to actively screen for irritability, anxiety, depression, mood changes, or behavioral symptoms, because levetiracetam has a real association with psychiatric side effects. So part of your follow-up visits with a patient on levetiracetam should include specifically asking about mood and behavior changes, not just seizure frequency.

Childhood absence epilepsy — a special pattern

This one has a very distinctive clinical picture: brief staring spells that start abruptly and end abruptly, returning immediately to baseline with no postictal confusion — no grogginess afterward at all. First-line treatment is ethosuximide. And here's an important trap: carbamazepine and phenytoin — two medications that work well for other seizure types — can actually worsen absence seizures. So this is a case where knowing the wrong-answer medications is just as important as knowing the right one.

Drug-resistant epilepsy

If a patient has failed two appropriately selected and tolerated antiseizure medications, given at therapeutic doses, that's the definition of drug-resistant epilepsy, and the next step is referral to a comprehensive epilepsy center. The key point to remember here is "appropriately selected and tolerated at therapeutic dose" — if a medication was underdosed, or the patient couldn't tolerate it and stopped early, that doesn't count as a true medication failure.

Safety counseling — the practical, everyday stuff

This is where N.P practice gets really concrete. Patients with epilepsy should avoid unobserved swimming — seizing in water is a drowning risk. Recommend showers instead of tub baths, for the same reason — you can't easily rescue someone from drowning in a bathtub if they seize. Driving restrictions vary state by state, so this needs individualized discussion, and — this is important for your own protection as a clinician — documentation. You want a clear note in the chart that you had this conversation.

Status epilepticus — the true emergency

Here's your emergency threshold: a generalized convulsive seizure lasting more than 5 minutes, or recurrent seizures without a return to baseline in between, is status epilepticus. This is a medical emergency, and benzodiazepines are first-line treatment — think lorazepam or diazepam. Clinically, this matters because prolonged seizure activity causes ongoing neuronal injury and can lead to respiratory compromise, so the longer it goes untreated, the worse the outcome.

Quick consolidation before we move on: syncope recovers fast, seizures leave patients foggy; epilepsy needs two unprovoked seizures; avoid valproate in reproductive-age patients when possible; absence epilepsy responds to ethosuximide, not carbamazepine or phenytoin; and seizures over five minutes are a benzodiazepine emergency.

Chapter Three: Headache

Primary versus secondary — the foundational split

Every headache you evaluate falls into one of two buckets. Primary headache means the headache itself is the disease — migraine, tension-type headache, cluster headache. Secondary headache means the headache is a symptom of something else going on — meningitis, intracranial hemorrhage, a mass lesion, vascular disease, or systemic illness. Your entire headache workup is essentially an exercise in figuring out which bucket you're in, because the management could not be more different — one bucket is often manageable in the outpatient setting, and the other can be an emergency.

Good news for the boring cases: a stable migraine pattern with a completely normal neurologic exam generally does not need routine neuroimaging. You don't need to scan every migraine patient — that's overutilization, and exam questions like to test whether you know when imaging is and isn't necessary.

Migraine — diagnostic criteria and treatment

Migraine without aura has a specific diagnostic pattern worth memorizing: recurrent headaches lasting 4 to 72 hours, with features that typically include unilateral location — one-sided, pulsating quality — throbbing, moderate to severe intensity, worsening with physical activity, and association with nausea and vomiting, or photophobia and phonophobia — that's sensitivity to light and sound.

For acute treatment of moderate-to-severe episodic migraine, when there's no contraindication, the combination of a triptan plus an ensaid has strong evidence behind it. And here's a very important negative point: opioids and butalbital are generally avoided for migraine treatment. Why? Because they don't address the underlying migraine mechanism well, they carry dependency risk, and — this connects to a concept coming up in a moment — they're strongly linked to medication overuse headache. A common exam question focuses on picking the triptan-plus-ensaid combination and steering away from the opioid or butalbital answer choice, even though those might seem like reasonable "just give something strong" options.

When do you add preventive therapy, meaning a daily medication to reduce migraine frequency rather than just treating attacks as they happen? Consider it when patients have frequent or disabling migraines — commonly defined as four or more migraine days per month — frequent use of acute medications, a poor response to acute treatment, or simply patient preference for prevention.

Medication overuse headache — a trap hiding inside the treatment

Here's a really important concept, because it's almost paradoxical: the very medications used to treat headache can, with overuse, cause a chronic daily headache pattern. Medication overuse headache is diagnosed when triptans, opioids, ergots, or combination analgesics are used 10 or more days per month, for more than 3 months, in a patient who already has an underlying headache disorder. Clinically, this matters because the instinct when a headache treatment "isn't working well enough" is often to use it more — but with these medication classes, more use can actually be making the headaches worse, creating a vicious cycle. This is exactly why we're cautious about opioids and butalbital for migraine in the first place.

Cluster headache — a totally different behavioral picture

I want you to build a strong visual contrast in your mind between migraine and cluster headache, because the exam loves this contrast. Migraine patients typically want to lie completely still in a dark, quiet room — movement makes it worse. Cluster headache patients are the opposite: they're often restless, agitated, pacing around, or rocking back and forth during an attack. If you picture someone pacing the room clutching one side of their head, that's your cluster headache patient.

For acute cluster treatment, the go-to is high-flow 100% oxygen delivered by a non-rebreather mask — this works remarkably fast for a lot of patients. Subcutaneous sumatriptan is also effective. The key point to remember is that oral medications are often too slow for cluster headache, because cluster attacks are short and severe, and by the time an oral pill kicks in, the attack may already be resolving on its own.

Red flags in headache — do not miss these

Thunderclap headache — one that reaches peak intensity within minutes, often described by patients as "the worst headache of my life" — is concerning for subarachnoid hemorrhage, bleeding around the brain, typically from a ruptured aneurysm. This requires urgent evaluation, usually starting with a non-contrast C.T of the head. This connects right back to what we said in the stroke section: C.T rules out hemorrhage.

New headache after age 50 should always prompt you to think about secondary causes rather than assuming it's a new primary headache disorder. One condition to specifically have on your radar in this age group is giant cell arteritis — also called temporal arteritis — an inflammatory condition of blood vessels. Watch for scalp tenderness, jaw claudication — meaning jaw pain with chewing that gets better with rest, visual symptoms, and elevated inflammatory markers like E.S.R or C.R.P. This one matters enormously because untreated giant cell arteritis can cause sudden, permanent vision loss — so a "new headache after 50 with jaw pain while chewing" is a pattern you should never brush off as tension headache.

Chapter Four: Concussion

Diagnosis doesn't require loss of consciousness

Let's clear up a really common misconception right away: concussion is a clinical diagnosis, based on the mechanism of injury, the patient's symptoms, and exam findings. Loss of consciousness is not required for a diagnosis of concussion — a lot of students assume you need a "knockout" for it to count, and that's simply not true. Someone can get their bell rung, never lose consciousness, and still have a concussion.

Routine C.T or M.R.I in concussion is often completely normal, and imaging is not required for every concussion. We reserve imaging for situations with red flags or when clinical decision rules suggest a higher-risk injury — things like worsening confusion, repeated vomiting, or a progressively worsening headache, which, remember from our red-flag table earlier, point toward needing an E.D evaluation and head C.T.

Management has changed — and this is testable

Here's a piece of outdated thinking that the exam specifically wants you to unlearn: strict "cocooning," meaning complete rest in a dark room until every symptom is gone, used to be standard advice. It is now considered outdated. The current, evidence-based approach is 24 to 48 hours of relative rest, followed by a gradual, symptom-limited return to cognitive and physical activity.

In other words, we ease patients back into normal life step by step, guided by their symptoms, rather than locking them away until they're perfect. A common exam question focuses on catching students who select the old "strict rest" answer instead of the current "brief rest, then gradual return to activity" answer.

For a low-risk patient — say, a young athlete with a Glasgow Coma Scale of 15, meaning fully alert and oriented, normal neuro exam, no vomiting, no seizure activity, and no signs of skull fracture — routine neuroimaging isn't indicated. That combination of clean findings tells you it's safe to manage this as a straightforward concussion without a C.T scan.

When to refer onward

If symptoms persist around the 4-week mark — especially dizziness, motion sensitivity, difficulty reading, oculomotor symptoms (that's eye-movement related symptoms), or the patient still can't return to school or work — that's your cue to refer for concussion-focused follow-up. In these persistent cases, consider vestibular rehabilitation, which retrains the balance system, and vision therapy evaluation for ongoing visual complaints. Clinically, this matters because a subset of concussion patients develop what's called post-concussion syndrome, and early, targeted rehab can meaningfully improve their recovery trajectory.

Chapter Five: Neurodegenerative Disorders

Now we're shifting gears from acute, time-sensitive presentations to chronic, progressive conditions. But don't relax too much — there are still red flags buried in here, particularly around A.L.S.

Alzheimer disease

The classic pattern is gradual, progressive short-term memory loss — patients repeat questions, and you'll often see impaired instrumental activities of daily living first, like managing medications or finances, before more basic self-care is affected. Treatment-wise, cholinesterase inhibitors — these work by boosting acetylcholine levels in the brain, a neurotransmitter important for memory — can provide modest symptomatic benefit in mild-to-moderate disease. Notice the word "modest" — these medications don't reverse or cure Alzheimer's, they provide some symptomatic help.

Parkinson disease

Here's a definitional point that trips a lot of students up: bradykinesia — that's slowness of movement — is required for a Parkinson disease diagnosis, plus either resting tremor or rigidity. The key point to remember is that tremor alone is not enough to diagnose Parkinson disease. You need that bradykinesia component. This matters because plenty of conditions cause tremor, and if you diagnose Parkinson's off tremor alone, you'll misdiagnose people with essential tremor or other tremor disorders.

A.L.S — amyotrophic lateral sclerosis

This is the one neurodegenerative disorder in this list that behaves like an urgent referral, not a routine chronic-disease follow-up. The pattern is progressive, often asymmetric weakness, with muscle wasting, fasciculations — those are small, visible muscle twitches under the skin, hyperreflexia, and spasticity. The key diagnostic concept: A.L.S involves both upper and lower motor neuron findings simultaneously — hyperreflexia and spasticity are upper motor neuron signs, while wasting and fasciculations are lower motor neuron signs. Seeing both patterns together in a progressively weakening patient is the hallmark, and it should prompt urgent neurology and multidisciplinary referral, because A.L.S eventually threatens respiratory and swallowing function.

Frontotemporal dementia

This one is a great contrast case with Alzheimer's. Instead of memory loss being the presenting problem, frontotemporal dementia presents early with personality changes, behavioral changes, or language changes — disinhibition, loss of empathy, socially inappropriate behavior. The key point to remember: memory may be relatively preserved early on, compared with Alzheimer disease. So if a family says "he's just not himself, he's saying rude things, he's lost his social filter, but his memory actually seems okay" — that pattern should make you think frontotemporal dementia rather than Alzheimer's.

Lewy body dementia

This one has a very distinctive triad-ish pattern: fluctuating cognition — meaning good days and bad days, or even good hours and bad hours, visual hallucinations that are typically well-formed, meaning detailed and specific rather than vague shadows, parkinsonism — movement symptoms similar to Parkinson disease, and R.E.M sleep behavior disorder, where patients physically act out their dreams during sleep. The key point to remember: watch for well-formed visual hallucinations combined with cognitive fluctuation — that combination is a strong signal for Lewy body dementia specifically.

Working up cognitive complaints properly

Before you slap a neurodegenerative label on someone, you need to rule out reversible or contributing causes. Order a C.B.C, a C.M.P, T.S.H to check thyroid function, vitamin B.12 level, screen for depression — because depression can absolutely mimic cognitive impairment, sometimes called pseudodementia — review medications for cognitive side effects, and consider brain imaging when indicated. This step matters enormously in practice because some of these causes, like B.12 deficiency or hypothyroidism, are fully treatable, and missing them means a patient gets an incorrect, permanent diagnosis.

For screening tools, know that MoCA — the Montreal Cognitive Assessment — is generally more sensitive than the M.M.S.E, the Mini-Mental State Exam, for detecting mild cognitive impairment. So if you're worried about early, subtle cognitive change, MoCA is the better screening tool to reach for.

A newer pharmacology consideration: aria

This is a more modern addition to the field: anti-amyloid antibody therapies, a newer class of Alzheimer's treatments, can cause something called aria — amyloid-related imaging abnormalities — which includes brain edema (swelling) or hemorrhage. If a patient on one of these therapies develops new severe headache, confusion, focal neurologic deficits, visual symptoms, dizziness, or seizures, that requires urgent evaluation. This is a good example of how new medications bring new monitoring responsibilities — you can't just start the drug and forget about it.

Chapter Six: Neuroimmunology

Let's shift into immune-mediated disorders of the nervous system — conditions where the body's own immune system attacks nerve tissue, either in the central nervous system (brain and spinal cord) or the peripheral nervous system.

Multiple sclerosis

M.S classically presents in young adults, with optic neuritis — inflammation of the optic nerve, causing vision changes, often painful with eye movement, sensory symptoms, weakness, gait changes, and fatigue. M.R.I shows lesions in characteristic locations within the central nervous system. As the N.P, your job is to recognize relapse symptoms — a new or worsening neurologic symptom lasting more than 24 hours. Significant relapses are often treated with high-dose I.V methylprednisolone, a corticosteroid, to hasten recovery — it doesn't change the long-term disease course, but it can shorten how long a relapse lasts.

Myasthenia gravis

M.G has a very distinctive functional pattern: fluctuating, fatigable weakness — meaning weakness that gets worse with activity and improves with rest. Ocular symptoms, like drooping eyelids or double vision, and bulbar symptoms, affecting speech and swallowing, are common. Here's the emergency version: bulbar weakness, shortness of breath — this is myasthenic crisis, and it's a genuine emergency because it threatens the airway and breathing.

Now, here's a pharmacology pearl that's incredibly high-yield and easy to overlook: certain medications can worsen myasthenia gravis. Specifically, avoid or use caution with fluoroquinolone antibiotics, aminoglycoside antibiotics, and magnesium. Picture this scenario, because it's a classic exam vignette: a patient with known myasthenia gravis develops pneumonia, and you're choosing an antibiotic. If you reach for a fluoroquinolone without thinking, you could tip that patient into a myasthenic crisis. So M.G patients need a "do not use" medication list, the same way a penicillin-allergic patient does.

Guillain-Barré syndrome, or G.B.S

We've touched on this already, but let's nail it down as its own entity. G.B.S presents with rapid, progressive, ascending weakness, areflexia (loss of reflexes), often occurring after an infection — the immune system, having just fought off an infection, mistakenly attacks peripheral nerves. This requires emergency referral, because of the real risk of respiratory failure and autonomic instability — meaning things like unstable blood pressure and heart rate.

Do not manage suspected G.B.S as routine outpatient neuropathy. That sentence is basically a direct exam warning: this looks like "just neuropathy" if you're not paying attention to the ascending, rapidly progressive pattern, but it can kill a patient through respiratory failure if it's not caught and monitored appropriately.

N.M.O.S.D — neuromyelitis optica spectrum disorder

This condition is important to distinguish from typical M.S because the two require different management approaches. N.M.O.S.D classically causes severe optic neuritis, often affecting both eyes, and something called longitudinally extensive transverse myelitis — spinal cord inflammation extending across three or more vertebral segments, which is much more extensive than what you typically see in M.S. The key point to remember: N.M.O.S.D attacks tend to be more severe than typical M.S attacks, and mistaking one for the other can lead to inappropriate treatment.

Before starting immunosuppression — primary care's role

If a patient is about to start immunosuppressive therapy for one of these conditions, primary care and the N.P have important co-management responsibilities: screen for infections like hepatitis B and tuberculosis as indicated, update needed vaccines before therapy begins when possible — and remember that live vaccines generally need to be completed before immunosuppression starts, because giving a live vaccine to an already-immunosuppressed patient can be dangerous. Also, obtain baseline labs and assess pregnancy status when relevant, and — this is easy to forget — keep up with routine preventive health screening rather than letting it fall by the wayside just because the patient now has a complex neurologic diagnosis.

Chapter Seven: Peripheral Nervous System Disorders

Peripheral neuropathy

The classic pattern here is length-dependent polyneuropathy: a slowly progressive, symmetric, stocking-and-glove sensory pattern that begins in the toes — think about it like the nerve endings farthest from the spinal cord getting affected first, which is why it starts distally, in the feet, before moving proximally. This is extremely common in diabetes.

Here's a great clinical-pharmacology connection: in a patient on long-term metformin, you should include vitamin B.12 with methylmalonic acid in your neuropathy workup. Why? Because metformin is known to interfere with B.12 absorption over time, and B.12 deficiency itself causes a neuropathy that can look just like diabetic neuropathy — so in a diabetic patient on metformin with neuropathy symptoms, you have to ask: is this diabetic neuropathy, B.12 deficiency neuropathy, or both?

Red flags that should make you refer urgently to neurology rather than manage this as routine diabetic neuropathy: acute onset (sudden rather than gradual), asymmetry (one side much worse than the other), rapid progression, and motor-predominant weakness (rather than primarily sensory symptoms). Typical diabetic peripheral neuropathy is slow, symmetric, and sensory-predominant — anything that breaks that pattern needs a closer look.

For treatment, in older adults or patients with fall risk, topical lidocaine may be a reasonable choice for painful localized diabetic neuropathy, because it has minimal systemic absorption and therefore minimal systemic side effects — an important consideration in a population where you're trying to avoid drugs that cause sedation, dizziness, or drug interactions.

And a screening pearl worth memorizing: per A.D.A guidelines, type 2 diabetes patients should be screened for diabetic peripheral neuropathy at diagnosis, and then annually thereafter. This is a "know the interval" fact that shows up on exams.

Carpal tunnel syndrome

Carpal tunnel is a median nerve compression at the wrist, and the sensory distribution follows the median nerve: thumb, index finger, middle finger, and the radial half — meaning the thumb-side half — of the ring finger. A classic history is symptoms that wake the patient up at night, and improve when the patient shakes their hand out — sometimes called the "flick sign." First-line treatment is nighttime neutral wrist splinting, which keeps the wrist in a position that minimizes pressure on the median nerve while it passes through the carpal tunnel.

Bell's palsy

This is one of the highest-yield "don't miss the distinction" topics in all of neurology. Bell's palsy is a peripheral cranial nerve seven — the facial nerve — palsy, and it affects the entire side of the face, including the forehead. Contrast that with central, stroke-related facial weakness, which characteristically spares the forehead — because the forehead muscles receive some innervation from both sides of the brain, so a one-sided stroke doesn't fully knock out forehead movement, but Bell's palsy, being a problem with the nerve itself rather than the brain, takes out the whole side, forehead included. So the exam question is essentially: "Can this patient wrinkle their forehead on the affected side?"

If yes, think stroke. If no — the whole face, forehead included, is weak — think Bell's palsy.

Practically speaking, if the patient can't fully close their eye on the affected side, eye protection becomes your immediate priority: lubricating drops during the day, ointment and protection at night, because an eye that can't close is at serious risk for corneal drying and injury, potentially leading to corneal ulceration if it's not protected.

Guillain-Barré syndrome — the peripheral nerve emergency, revisited

Just to reinforce it one more time in this context: progressive bilateral leg weakness, difficulty walking, hyporeflexia or areflexia, and a recent history of G.I or respiratory illness — that combination should prompt E.D transfer. This bears repeating because it's the kind of presentation that could initially look like "just some weakness," but the trajectory toward respiratory failure makes outpatient management unsafe.

Let's pause here and connect the dots across this chapter: peripheral neuropathy is slow and symmetric — stable, chronic, outpatient. Carpal tunnel is a compressive, positional problem — very manageable outpatient with splinting. Bell's palsy is peripheral facial nerve weakness — mostly outpatient, but with an urgent eye-protection piece.

And G.B.S is the outlier — rapid, ascending, and dangerous. Recognizing which category a peripheral nerve complaint falls into is really the core skill being tested here.

Chapter Eight: Wound Care

Now let's shift entirely gears into wound care — a very different content area, but structurally, it follows the same underlying logic: pattern recognition, plus knowing when a wound needs urgent escalation versus routine management.

Normal wound healing, and when to worry

The first phase of wound healing is hemostasis — platelets rush to the injury, form a clot, and release signaling factors that kick off the rest of the healing cascade. Now here's a practical benchmark for your practice: a wound that isn't meaningfully improving after 4 to 6 weeks of appropriate care should trigger a reassessment. And notice what you're reassessing for — it's not just "try a different dressing." You're reassessing etiology (did we even get the underlying cause right?), perfusion (is blood flow adequate to heal?), infection (is something actively working against healing?), and adherence (is the patient actually following the plan — for example, are they actually offloading a diabetic foot ulcer, or still walking on it?).

Recognizing wound types by their story

This is where pattern recognition really pays off, because each wound type has a distinctive clinical fingerprint.

Diabetic foot ulcers classically appear as painless plantar ulcers — meaning on the sole of the foot — typically under a metatarsal head, often with a callus rim around it, occurring in a patient with sensory neuropathy. The word "painless" is key — because the neuropathy has knocked out protective sensation, patients can develop a serious ulcer without even feeling it. The treatment priority is offloading — taking pressure off that area — and often the best method is a nonremovable knee-high offloading device, sometimes called a total contact cast, when appropriate. "Nonremovable" matters because if patients can take a device off, adherence drops dramatically — the device forces offloading even when the patient might otherwise be tempted to walk normally.

Venous leg ulcers show up as shallow, irregular ulcers near the medial malleolus — that's the bony bump on the inner ankle — in what's called the "gaiter area." You'll typically see accompanying edema, hemosiderin staining — a brownish discoloration from blood breakdown products leaking into the skin over time — and varicosities, meaning visible varicose veins. The treatment priority is compression therapy, but — and this is critical — only if arterial flow is adequate. We'll come back to why in a moment.

Arterial, or P.A.D (peripheral arterial disease), ulcers have a completely different fingerprint: they're painful, well-demarcated or "punched-out" looking, with a pale wound base, shiny, hairless skin around them, diminished pulses, and — here's a distinguishing symptom — pain that's worse with elevation. Think about the physiology: elevating the leg makes it harder for blood to fight gravity and reach the foot when arterial flow is already compromised, so elevation makes arterial ulcer pain worse, while for a venous ulcer, elevation typically helps by reducing that dependent edema. The priority here is assessing perfusion and urgent vascular referral for severe ischemia.

Pressure injuries occur over bony prominences, in patients with immobility or other pressure and shear risk factors. Management is offloading the pressure and addressing the risk factors that led to it. A specific and testable pearl: stable, dry heel eschar — a hardened, dark, dry area of dead tissue on the heel — is usually left intact and simply protected, rather than debrided, as long as it's not infected or unstable. That might feel counterintuitive if your instinct is "wounds need debridement," but here, that dry eschar is actually functioning like a natural, protective cover over the wound bed.

The Time framework for assessment

When you're evaluating any chronic wound, use the Time framework to organize your thinking: Tissue — what's actually in the wound bed, healthy granulation tissue, or nonviable tissue; Infection or Inflammation — are there signs pointing toward infection; Moisture balance — is the wound too dry, too wet and macerated (meaning the surrounding skin is breaking down from excess moisture), or appropriately moist; and Edge — what's happening at the wound margins, is it advancing, undermined, or rolled.

At every wound visit, your documentation should include location, length, width, and depth, wound bed and tissue type, drainage characteristics, the condition of surrounding skin, pain level, odor, and serial photographs when available. This isn't just busywork — consistent, structured documentation is how you and other clinicians track whether a wound is actually improving over time, and it's also your legal and clinical safety net.

A.B.I, T.B.I, and figuring out vascular status

The ankle-brachial index, or A.B.I, compares blood pressure at the ankle to blood pressure at the arm, and it's your primary noninvasive tool for assessing arterial flow to the leg. Here's a nuance that trips people up: an A.B.I greater than 1.3 doesn't mean "great blood flow" — it actually suggests noncompressible, calcified vessels, which is common in patients with diabetes or chronic kidney disease. Their arteries are so stiffened by calcification that the blood pressure cuff can't compress them properly, giving you a falsely elevated reading. In that situation, you need a toe-brachial index, or T.B.I, instead, because the smaller vessels in the toes are less likely to be affected by that same calcification.

On the other end of the spectrum, an A.B.I less than 0.40 suggests severe peripheral arterial disease or chronic limb-threatening ischemia — a genuinely urgent situation. Here's a scenario worth locking into memory: a diabetic foot ulcer with an A.B.I of 0.38 requires urgent vascular referral. And this connects directly to a safety principle: do not start high-pressure compression therapy until you've confirmed adequate arterial flow. Why? Because if you compress a leg that doesn't have adequate arterial inflow, you can actually worsen ischemia and cause tissue damage — compression assumes good arterial flow with a venous or lymphatic problem on top of it, not a primary arterial supply problem.

Diabetic foot ulcers and infection — knowing when to treat, and when not to

If you can probe a diabetic foot ulcer down to bone — meaning your probe reaches bone through the wound — combined with an E.S.R greater than 70 millimeters per hour, that combination should raise real concern for osteomyelitis, a bone infection. M.R.I is typically the preferred imaging study when osteomyelitis is suspected, because it's much better than X-ray at detecting early bone infection and soft tissue involvement.

Now here's an important restraint principle: chronic wounds are frequently colonized with bacteria — that's just baseline reality for an open wound — but colonization is not the same thing as infection. Do not prescribe systemic antibiotics for drainage alone if there's no erythema (redness), warmth, purulence (pus), increased pain, fever, or other systemic symptoms. Overtreating colonization with antibiotics doesn't help the wound and contributes to antibiotic resistance. Along the same lines, superficial wound swabs are generally discouraged, because they tend to just grow whatever bacteria are colonizing the wound surface, rather than reflecting a true deep infection — so a positive swab culture doesn't automatically mean "treat with antibiotics."

Pressure injury risk and the Braden Scale

The Braden Scale is your standardized tool for assessing pressure injury risk, and it ranges from 6 to 23. Here's the key direction to remember: lower scores mean higher risk — which can feel backwards if you're used to scales where higher equals worse, so make sure you've got that orientation locked in. A score of 10 would represent very high risk, meaning this patient needs aggressive preventive measures — frequent repositioning, pressure-redistributing surfaces, careful skin checks.

And let's circle back to that heel eschar pearl one more time because it's so testable: stable, dry, noninfected heel eschar is generally left intact and protected, because it functions as a natural biological cover for the wound underneath. You'd only debride it if you start seeing signs of infection or instability, like fluctuance, drainage, odor, or the eschar becoming boggy or loose.

Clinical Application Section

Let's now run through a few realistic scenarios the way you'd actually encounter them in clinic or on a shift, and talk through the N.P reasoning in real time.

Scenario one. A 68-year-old presents with sudden vertigo, double vision, and slurred speech that started 90 minutes ago. Your brain should immediately flag this as posterior circulation stroke until proven otherwise — you've got three of the Deadly D's right there: dizziness, diplopia, dysarthria. Your first move is establishing last known well, and your first test is a point-of-care glucose, to rule out a hypoglycemic mimic.

Then you're moving quickly toward a non-contrast C.T to check for hemorrhage, with C.T.A on the table if there's any concern for large vessel occlusion. This is not a "let's watch and see" presentation — the time window for intervention is closing with every passing minute.

Scenario two. A 34-year-old woman with newly diagnosed focal epilepsy tells you she and her partner are hoping to start trying for a baby within the next year. This is exactly the scenario where you steer away from valproate, given its teratogenic and neurodevelopmental risk profile, and lean toward levetiracetam as a generally preferred alternative, while still counseling her on levetiracetam's own mood and behavioral side-effect profile.

Scenario three. A patient with known myasthenia gravis comes in with a productive cough, fever, and a chest X-ray consistent with pneumonia. Before reflexively reaching for a fluoroquinolone, you pause — fluoroquinolones can worsen myasthenic weakness, and so can aminoglycosides and magnesium. You select an alternative antibiotic class, and you're watching this patient closely for any bulbar symptoms or breathing difficulty that would suggest an evolving myasthenic crisis layered on top of the infection.

Scenario four. A 61-year-old with type 2 diabetes has a painless ulcer on the plantar surface of the foot, under the first metatarsal head, with a thick callus rim. There's no pain reported at all, which — rather than being reassuring — is actually the red flag itself, telling you sensory neuropathy is present. Your priority is offloading, likely with a nonremovable device, and you're also assessing perfusion, because if arterial flow is compromised on top of the neuropathy, that changes urgency and management substantially.

Scenario five. A patient with the same diabetic foot ulcer has an A.B.I of 0.38 on vascular testing. This isn't a "continue routine wound care and follow up in a month" situation — an A.B.I that low signals severe ischemia, and this patient needs urgent vascular referral, full stop, before you consider things like aggressive debridement or compression.

Exam Preparation: High-Yield Facts and Common Traps

Let's do a rapid-fire consolidation of the concepts most likely to appear as distractors or as the "gotcha" on your exam.

Trap one: seeing "normal C.T" or "normal M.R.I" and assuming that rules out a serious problem. It doesn't — early ischemic stroke commonly looks normal on initial C.T, and a normal head C.T does not rule out meningitis. Don't let normal imaging falsely reassure you when the clinical picture — fever, neck stiffness, altered mental status — still says something dangerous is happening.

Trap two: treating vertigo as automatically benign. Always screen for the Deadly D's before writing off vertigo as "probably vestibular."

Trap three: reaching for opioids or butalbital as first-line acute migraine treatment. The evidence-based first choice is triptan plus ensaid, and overusing those "avoid" medications is part of what drives medication overuse headache.

Trap four: assuming a single seizure equals epilepsy. You need two unprovoked seizures more than 24 hours apart. A provoked seizure — like one from severe hypoglycemia — doesn't count toward that diagnosis.

Trap five: choosing carbamazepine or phenytoin for absence seizures. These can actually worsen absence seizures. Ethosuximide is your first-line agent there.

Trap six: prescribing strict, prolonged rest for concussion. Current guidance is a short period of relative rest, then gradual, symptom-guided return to activity.

Trap seven: diagnosing Parkinson disease off tremor alone. Bradykinesia is a required feature.

Trap eight: forgetting that Bell's palsy involves the forehead, while a central (stroke) facial droop spares it. This distinction is one of the most classic peripheral-versus-central exam questions in all of neurology.

Trap nine: treating chronic wound drainage with antibiotics just because there's drainage present. Colonization is not infection — you need actual signs of infection: erythema, warmth, purulence, increasing pain, fever, or systemic symptoms.

Trap ten: starting compression therapy on a leg ulcer before confirming adequate arterial flow. Compression without adequate perfusion can worsen ischemia.

Trap eleven: misreading a high A.B.I as good news. An A.B.I over 1.3 means noncompressible vessels, not healthy vessels — go get a toe-brachial index instead.

Trap twelve: debriding a stable, dry, noninfected heel eschar just because "wounds should be debrided." Leave it alone unless there are signs of infection or instability.

Final Review and Recap

Let's bring it all together. The unifying theme across this entire unit is recognizing which presentations demand emergency-level urgency, and which are safe for structured outpatient management. Time-sensitive stroke care hinges on last known well, a glucose check, and non-contrast C.T to rule out hemorrhage before anything else.

Status epilepticus is anything over five minutes of convulsive seizure activity, treated first with benzodiazepines. Thunderclap headache and new headache after 50 both deserve urgent secondary-cause workups. G.B.S and myasthenic crisis both threaten the airway and demand emergency referral, and A.L.S demands urgent — though not emergency-department-level — specialty referral.

In wound care, an A.B.I under 0.40 and probe-to-bone with a high E.S.R are your two big triggers for urgent escalation.

Now let's test your recall with a few self-test questions.

Question one. A 55-year-old presents with sudden onset dizziness, double vision, and difficulty speaking. What's the most important next diagnostic step to think through, and what pattern does this represent?

Answer: This is a classic posterior circulation stroke presentation — the Deadly D's. After confirming last known well and checking point-of-care glucose, you'd move toward non-contrast C.T to rule out hemorrhage, with C.T.A if large vessel occlusion is a concern.

Question two. A patient with epilepsy is on valproate and mentions she'd like to become pregnant in the next year. What should you consider changing, and why?

Answer: Consider transitioning to levetiracetam, since valproate carries major teratogenic and neurodevelopmental risk, whereas levetiracetam is generally preferred in patients of reproductive potential — while still monitoring for levetiracetam's mood and behavioral side effects.

Question three. True or false: a normal C.T head rules out meningitis.

Answer: False. Don't let a normal C.T falsely reassure you when the clinical picture is concerning for meningitis.

Question four. What distinguishes central (stroke) facial weakness from Bell's palsy on exam?

Answer: Central facial weakness from stroke spares the forehead, because the forehead has bilateral cortical innervation. Bell's palsy, a peripheral C.N 7 lesion, affects the entire side of the face, including the forehead.

Question five. A diabetic patient has a foot ulcer with an A.B.I of 0.38. What's your next step?

Answer: Urgent vascular referral — this A.B.I indicates severe ischemia or chronic limb-threatening ischemia, and you should not initiate high-pressure compression until adequate arterial flow is confirmed.

Question six. Why do we avoid fluoroquinolones in a patient with myasthenia gravis who needs antibiotics?

Answer: Fluoroquinolones — along with aminoglycosides and magnesium — can worsen myasthenic weakness and potentially precipitate a myasthenic crisis, which threatens breathing and swallowing.

Question seven. A patient has chronic wound drainage but no erythema, warmth, purulence, fever, or increased pain. Should you start antibiotics?

Answer: No. This represents colonization, not infection. Systemic antibiotics aren't indicated for drainage alone without clinical signs of infection.

That wraps up our review. The throughline across every single topic today was the same clinical instinct: identify the pattern, know the red flags that change everything, and always ask yourself whether this is a "safe to manage here" situation or a "this needs to move fast" situation. Keep running through those look-alike comparisons — Bell's palsy versus stroke, migraine versus cluster, syncope versus seizure, venous versus arterial versus diabetic ulcers — because that kind of side-by-side contrast is exactly how these exam questions are built. Good luck on your test, and nice work getting through this whole session.

You have reached the end of the text.